In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Influenza Tests are laboratory based tests used to identify active or suspected influenza infections, using a combination of molecular diagnostics and immunoassay. GlobalData uses proprietary data and analytics to provide a comprehensive report on the influenza tests devices market, including market shares of different players within Japan. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the influenza tests market in Japan was Sekisui Diagnostics followed by Abbott Laboratories, Becton Dickinson and Co, Quidelortho, F. Hoffmann-La Roche, Thermo Fisher Scientific, DiaSorin and Danaher.
Influenza Tests include Influenza Antigen Tests, Influenza Multiplex NAATs, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs).
The value of the influenza tests devices market within Japan was expected to be over $0.7m in 2023.
For the latest complete market share analysis of influenza tests device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.